John,

Join Health Affairs on May 29 for an exclusive Insider virtual event exploring the changes at the FDA under the second Donald Trump administration.

If you aren't an Insider, become an Insider today to get access to exclusive events and more.

The second Trump administration's restructuring of the federal branch of government has affected HHS, particularly the U.S. Food and Drug Administration (FDA).

In this 60-minute virtual event, moderator Rachel Sachs along with panelists Richard Hughes IV and Arti Rai will review the policy and administrative changes at the FDA during Trump’s first 100 days in office during his second administration. 

With a focus on vaccine policy and drug development and innovation, attendees will leave with a better understanding of what’s happened at the FDA and what may come in the near future.